Details for New Drug Application (NDA): 020279
✉ Email this page to a colleague
The generic ingredient in DERMATOP E EMOLLIENT is prednicarbate. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the prednicarbate profile page.
Summary for 020279
Tradename: | DERMATOP E EMOLLIENT |
Applicant: | Valeant Bermuda |
Ingredient: | prednicarbate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 29, 1993 | TE: | RLD: | Yes |
Expired US Patents for NDA 020279
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Bermuda | DERMATOP E EMOLLIENT | prednicarbate | CREAM;TOPICAL | 020279-001 | Oct 29, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription